Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Amyes

Showing results (31-40 of 161) with videos related to

Pageof 17
Sort By:
Journal of Medical Microbiology|June 1, 1995
Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acidC J Thomson, S G Amyes
British Medical Bulletin|January 1, 1984
Bacterial resistance to antifolate chemotherapeutic agents mediated by plasmidsJ T Smith, S G Amyes
The Journal of Pharmacy and Pharmacology|December 1, 1977
Antagonism of aminoglycoside antibiotic action [proceedings]S G Amyes, J T Smith
The Journal of Antimicrobial Chemotherapy|November 18, 1998
Extended-spectrum beta-lactamases: the role of inhibitors in therapyS G Amyes, R S Miles
The Journal of Antimicrobial Chemotherapy|November 1, 1985
The effect of a range of antimicrobial drugs on the haemagglutination of two clinical isolates from urinary tract infectionsB A Hales, S G Amyes
Journal of Medical Microbiology|December 1, 1986
Acquisition of a gene encoding mannose-resistant haemagglutinating fimbriae by a resistance plasmid during long-term urinary infectionB A Hales, S G Amyes
Journal of General Microbiology|August 1, 1986
The transfer of genes encoding production of mannose-resistant haemagglutinating fimbriae from uropathogenic enterobacteriaB A Hales, S G Amyes
Journal of Medical Microbiology|June 1, 1990
Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16C S Lewin, S G Amyes
Antimicrobial Agents and Chemotherapy|August 1, 1986
Plasmid penicillin resistance in Vibrio cholerae: identification of new beta-lactamase SAR-1A J Reid, S G Amyes
The Journal of Antimicrobial Chemotherapy|May 1, 1993
Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitorsC J Thomson, S G Amyes
Pageof 17

Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
Journal of Medical Microbiology|June 1, 1995
Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acidC J Thomson, S G Amyes
British Medical Bulletin|January 1, 1984
Bacterial resistance to antifolate chemotherapeutic agents mediated by plasmidsJ T Smith, S G Amyes
The Journal of Pharmacy and Pharmacology|December 1, 1977
Antagonism of aminoglycoside antibiotic action [proceedings]S G Amyes, J T Smith
The Journal of Antimicrobial Chemotherapy|November 18, 1998
Extended-spectrum beta-lactamases: the role of inhibitors in therapyS G Amyes, R S Miles
The Journal of Antimicrobial Chemotherapy|November 1, 1985
The effect of a range of antimicrobial drugs on the haemagglutination of two clinical isolates from urinary tract infectionsB A Hales, S G Amyes
Journal of Medical Microbiology|December 1, 1986
Acquisition of a gene encoding mannose-resistant haemagglutinating fimbriae by a resistance plasmid during long-term urinary infectionB A Hales, S G Amyes
Journal of General Microbiology|August 1, 1986
The transfer of genes encoding production of mannose-resistant haemagglutinating fimbriae from uropathogenic enterobacteriaB A Hales, S G Amyes
Journal of Medical Microbiology|June 1, 1990
Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16C S Lewin, S G Amyes
Antimicrobial Agents and Chemotherapy|August 1, 1986
Plasmid penicillin resistance in Vibrio cholerae: identification of new beta-lactamase SAR-1A J Reid, S G Amyes
The Journal of Antimicrobial Chemotherapy|May 1, 1993
Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitorsC J Thomson, S G Amyes
Pageof 17